A randomized clinical trial of a group cognitive-behavioral therapy to reduce alcohol use among human immunodeficiency virus-infected outpatients in western Kenya

被引:21
|
作者
Papas, Rebecca K. [1 ]
Gakinya, Benson N. [2 ]
Mwaniki, Michael M. [3 ]
Lee, Hana [4 ]
Keter, Alfred K. [3 ]
Martino, Steve [5 ]
Klein, Debra A. [6 ]
Liu, Tao [4 ]
Loxley, Michelle P. [4 ]
Sidle, John E. [7 ]
Schlaudt, Kathryn [8 ]
Nafula, Tobista [3 ]
Omodi, Victor M. [3 ]
Baliddawa, Joyce B. [2 ]
Kinyanjui, Daniel W. [2 ]
Maisto, Stephen A. [9 ]
机构
[1] Brown Univ, Alpert Med Sch, Providence, RI 02906 USA
[2] Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya
[3] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya
[4] Brown Univ, Sch Publ Hlth, Providence, RI 02906 USA
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] Right Response LLC, Minneapolis, MN USA
[7] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[8] Lutheran World Fdn, Gore, Chad
[9] Syracuse Univ, Syracuse, NY USA
关键词
Alcohol; cognitive-behavioral therapy; HIV; Kenya; paraprofessional; randomized clinical trial; COLLABORATIVE PROJECT; HIV-INFECTION; COPING SKILLS; SELF-REPORTS; DRINKING; INTERVENTION; CONSUMPTION; WOMEN; RISK; PHOSPHATIDYLETHANOL;
D O I
10.1111/add.15112
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and aims Culturally relevant and feasible interventions are needed to address limited professional resources in sub-Saharan Africa for behaviorally treating the dual epidemics of HIV and alcohol use disorder. This study tested the efficacy of a cognitive-behavioral therapy (CBT) intervention to reduce alcohol use among HIV-infected outpatients in Eldoret, Kenya. Design Randomized clinical trial. Setting A large HIV outpatient clinic in Eldoret, Kenya, affiliated with the Academic Model Providing Access to Healthcare collaboration. Participants A total of 614 HIV-infected outpatients [312 CBT; 302 healthy life-styles (HL); 48.5% male; mean age: 38.9 years; mean education 7.7 years] who reported a minimum of hazardous or binge drinking. Intervention and comparator A culturally adapted six-session gender-stratified group CBT intervention compared with HL education, each delivered by paraprofessionals over six weekly 90-minute sessions with a 9-month follow-up. Measurements Primary outcome measures were percentage of drinking days (PDD) and mean drinks per drinking day (DDD) computed from retrospective daily number of drinks data obtained by use of the time-line follow-back from baseline to 9 months post-intervention. Exploratory analyses examined unprotected sex and number of partners. Findings Median attendance was six sessions across condition. Retention at 9 months post-intervention was high and similar by condition: CBT 86% and HL 83%. PDD and DDD marginal means were significantly lower in CBT than HL at all three study phases. Maintenance period, PDD - CBT = 3.64 (0.696), HL = 5.72 (0.71), mean difference 2.08, 95% confidence interval (CI) = 0.13 - 4.04; DDD - CBT = 0.66 (0.96), HL = 0.98 (0.098), mean difference = 0.31, 95% CI = 0.05 - 0.58. Risky sex decreased over time in both conditions, with a temporary effect for CBT at the 1-month follow-up. Conclusions A cognitive-behavioral therapy intervention was more efficacious than healthy lifestyles education in reducing alcohol use among HIV-infected Kenyan outpatient drinkers.
引用
收藏
页码:305 / 318
页数:14
相关论文
共 50 条
  • [41] Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
    Glasner, Suzette
    Garneau, Helene Chokron
    Ang, Alfonso
    Ray, Lara
    Venegas, Alexandra
    Rawson, Richard
    Kalichman, Seth
    PLOS ONE, 2020, 15 (03):
  • [42] Editorial response: Discordance between virological, immunologic, and clinical outcomes of therapy with protease inhibitors among human immunodeficiency virus-infected patients
    Goetz, MB
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : 1431 - 1434
  • [43] Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: Results from a randomized, controlled clinical trial
    Gnann, JW
    Crumpacker, CS
    Lalezari, JP
    Smith, JA
    Tyring, SK
    Baum, KF
    Borucki, MJ
    Joseph, WP
    Mertz, GJ
    Steigbigel, RT
    Cloud, GA
    Soong, SJ
    Sherrill, LC
    DeHertogh, DA
    Whitley, RJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1139 - 1145
  • [44] The Effectiveness of Acceptance and Commitment Therapy and Cognitive-Behavioral Therapy in Enhancing Resiliency and Quality of Life Among Multiple Sclerosis Patients: A Randomized Clinical Trial Study
    Karimi, Mohsen
    Thani, Fatemeh Narenji
    Naqhsh, Zahra
    Ghazaghi, Tahereh
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2022, 16 (01)
  • [45] Effects of Internet Cognitive-Behavioral Therapy on Depressive Symptoms and Surrogates of Cardiovascular Risk in Human Immunodeficiency Virus: A Pilot, Randomized, Controlled Trial (vol 7, ofaa280, 2020)
    Gupta, S. K.
    Slaven, J. E.
    Liu, Z.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (06):
  • [46] Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial
    Samet, Jeffrey H.
    Tsui, Judith, I
    Cheng, Debbie M.
    Liebschutz, Jane M.
    Lira, Marlene C.
    Walley, Alexander Y.
    Colasanti, Jonathan A.
    Forman, Leah S.
    Root, Christin
    Shanahan, Christopher W.
    Sullivan, Margaret M.
    Bridden, Carly L.
    Abrams, Catherine
    Harris, Catherine
    Outlaw, Kishna
    Armstrong, Wendy S.
    del Rio, Carlos
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2052 - E2058
  • [48] Annual zoledronate increases bone density in highly active Antiretroviral therapy-treated human immunodeficiency virus-infected men: A randomized controlled trial
    Bolland, Mark J.
    Grey, Andrew B.
    Horne, Anne M.
    Briggs, Simon E.
    Thomas, Mark G.
    Ellis-Pegler, Rod B.
    Woodhouse, Andrew F.
    Gamble, Greg D.
    Reid, Ian R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1283 - 1288
  • [49] COGNITIVE-BEHAVIORAL GROUP THERAPY VERSUS GROUP PSYCHOTHERAPY FOR SOCIAL ANXIETY DISORDER AMONG COLLEGE STUDENTS: A RANDOMIZED CONTROLLED TRIAL (vol 28, pg 1034, 2011)
    Bjornsson, Andri S.
    Bidwell, L. Cinnamon
    Brosse, Alisha L.
    Carey, Gregory
    Hauser, Monika
    Seghete, Kristen L. Mackiewicz
    Schulz-Heik, R. Jay
    Weatherley, Donald
    Erwin, Brigette A.
    Craighead, W. Edward
    DEPRESSION AND ANXIETY, 2013, 30 (11) : 1145 - 1146
  • [50] Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial
    Vujanovic, Anka A.
    Smith, Lia J.
    Green, Charles E.
    Lane, Scott D.
    Schmitz, Joy M.
    CONTEMPORARY CLINICAL TRIALS, 2018, 65 : 123 - 129